Anti-CGRP monoclonal antibodies in migraine: current perspectives.
about
The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis.The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine.Phase 1, Randomized, Double-blind, Placebo-controlled, Single-dose and Multiple-dose Studies of Erenumab in Healthy Subjects and Patients With Migraine.Lasmiditan for the treatment of migraine.Chronic migraine treatment: from OnabotulinumtoxinA onwards.Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.An antidote approach to reduce risk and broaden utility of antibody-based therapeutics.[EXPRESS] Monoclonal antibodies for chronic pain: a practical review of mechanisms and clinical applications.Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab.The Application of CGRP(r) Monoclonal Antibodies in Migraine Spectrum: Needs and Priorities.Acute treatment of migraine: quo vadis?The Rodent Tibia Fracture Model: A Critical Review and Comparison with the Complex Regional Pain Syndrome Literature.The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy.A Critical Evaluation on MOH Current Treatments.
P2860
Q36340711-880DA80B-7695-42DF-B059-7523981E6999Q37713262-95D37841-57F1-4D33-B1A8-C303C85A38DCQ38665422-2B70009F-8C8D-4AFF-A42D-DB8AC3F610C4Q38771819-11F6FDEB-BB9F-4FDF-B94E-EC412665E34BQ38866988-FB4AE662-2996-4030-A774-3283D3B278BEQ39242677-7A4CD4EE-9983-4047-810E-FDC566F6380AQ39433833-ACBAFAC5-669A-412C-B053-934A9ABA0A55Q40309222-E1556D70-DA15-4E6D-A695-7E3CE63CC763Q46156381-39F329E6-7DC1-44E3-9DBA-9962BF971DB4Q47095158-92B70407-0C37-47C9-B29C-19B555611BC3Q47619115-EC154900-8245-4BD0-8FC5-723D730CD7A6Q48131347-1F7E8101-94AB-455C-B072-186764BFC701Q52312548-56BA9518-0DBB-416F-9800-805EE6B55E8BQ52608146-95D2D1BA-C40A-462D-9974-796C63061F45Q54795534-7243E3AA-419F-4DD4-B936-B9D558E29D1E
P2860
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
@ast
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
@en
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
@nl
type
label
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
@ast
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
@en
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
@nl
prefLabel
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
@ast
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
@en
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
@nl
P2093
P2860
P50
P1476
Anti-CGRP monoclonal antibodies in migraine: current perspectives.
@en
P2093
Giannapia Affaitati
Maria Adele Giamberardino
Raffaele Costantini
P2860
P2888
P304
P356
10.1007/S11739-016-1489-4
P577
2016-06-23T00:00:00Z